Table 1.
Patient and Treatment Characteristics.
| Patient and Target Characteristics (n = 86) | |
|---|---|
| Age in years—median (range)a | 9 (1-20) |
| Gender, male—n (%)b | 32 (56%) |
| Race—n (%)c | |
| White | 36 (61%) |
| Black | 10 (17%) |
| Other | 13 (22%) |
| KPS—median (range)d | 80 (40-100) |
| Tumor location—n (%)e | |
| Supratentorial | 30 (43%) |
| Infratentorial | 19 (27%) |
| Other | 21 (30%) |
| IGRT characteristicsf | |
| Total dose—median (range)g | 54 Gy (24-59.4 Gy) |
| Immobilization device—n (%)h | |
| Short mask | 43 (68%) |
| Long mask | 20 (32%) |
| Baseline steroids use—n (%)i | |
| Yes | 38 (48%) |
| No | 41 (52%) |
| Anesthesia required—n (%)j | |
| Yes | 26 (32%) |
| No | 55 (68%) |
| Other treatment characteristics | |
| Surgical resection—n (%)k | |
| Yes | 54 (68%) |
| No | 26 (32%) |
| Extent of resection—n (%)l | |
| Gross residual disease | 17 (40%) |
| No gross residual disease | 25 (60%) |
| Chemotherapy—n (%)m | |
| Pre- or concurrent with IGRT | 41 (68%) |
| After IGRT | 15 (25%) |
| None | 5 (8%) |
Abbreviations: KPS, Karnofsky Performance Status; IGRT, image-guided radiotherapy.
a Missing data: 2. b Missing data: 29. c Missing data: 27. d Missing data: 5. e Missing data: 16. f Missing data: 6. g Missing data: 23. h Missing data: 7. i Missing data: 5. j Missing data: 6. k Missing data: 23. l Missing data: 27. m Includes sites requiring craniospinal and whole ventricle radiation.